Trademark: OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES
Mark Identification
OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES
Click here to search for trademarks similar to OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES
Proof of use for OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES
We do not have any records of a proof of use for OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES at this moment.
Click here to add a proof of use for OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES
Possible trademark infringements of OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES
Basic Information about OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES
- Serial Number
- 87165087
- Filing Date
- 08 Sep 2016
- Registration Number
- 5344095
- Registration Date
- 28 Nov 2017
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES on the blockchain with WikiTrademarks.io.
- First use of OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES anywhere
- OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES was first used on 18 Nov 2014 for the primary classification of goods and services, international, 031 (Natural agricultural products)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 031
- US Codes
- 001; 046
Who owns OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES?
1. OMNIAB, INC. Emeryville CA
2. Open Monoclonal Technology, Inc. San Diego CA
3. Open Monoclonal Technology, Inc. Palo Alto CA
4. Open Monoclonal Technology, Inc. Palo Alto CA
Correspondent
- Francis P. Cislak BARNES & THORNBURG LLP
- 11 SOUTH MERIDIAN STREET
- INDIANAPOLIS, IN 46204-3535
- UNITED STATES
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on OMNIMOUSE NATURALLY OPTIMIZED HUMAN ANTIBODIESBODIES